Home 2018
Archives
ASH: High Response to Tx After Checkpoint Blockade in NHL, HL
Immunotherapy boosts later therapy for relapsed, refractory non-Hodgkin, Hodgkin lymphoma
ASH: Ibrutinib Tops Bendamustine + Rituximab for CLL
Improved progression-free survival with ibrutinib for older adults with untreated CLL
RSNA: Mammography May Benefit 30-Year-Olds With Risk Factors
Early screening may benefit those with dense breasts, personal/family history of breast cancer
RSNA: Refractory Back Pain Responds to CT-Guided Pulsed RF
Significantly greater overall improvement seen in pain and disability scores in the first year
AI-Based Smartphone App Can Help Cut Cancer Pain Severity
App can cut both severity of advanced cancer patients' reported pain and hospital admissions
RSNA: Mammography Has Value in Women Age 75 or Older
Cancer detection rate is 8.4/1,000 exams in older women; 98 percent of cancers surgically excised
Immunotherapy Side Effects May Be More Common Than Thought
Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings
RSNA: Ultrasound of Shoulder Muscle May Help Diagnose T2DM
Echogenic-appearing deltoid muscle appears to be a powerful predictor of diabetic status
ACAAI: Oral Immunotherapy Is Protective in Peanut Allergy
More patients receiving AR101 able to ingest ≥600 mg peanut protein without dose-limiting symptoms
ACAAI: Almost 2 Percent of Children Have Milk Allergy
Among children with food allergy, 53 percent of infants have milk allergy vs. 15 percent of teens
